GB9208740D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9208740D0
GB9208740D0 GB929208740A GB9208740A GB9208740D0 GB 9208740 D0 GB9208740 D0 GB 9208740D0 GB 929208740 A GB929208740 A GB 929208740A GB 9208740 A GB9208740 A GB 9208740A GB 9208740 D0 GB9208740 D0 GB 9208740D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929208740A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB929208740A priority Critical patent/GB9208740D0/en
Publication of GB9208740D0 publication Critical patent/GB9208740D0/en
Priority to IL105375A priority patent/IL105375A0/en
Priority to JP5518882A priority patent/JPH07505897A/en
Priority to MX9302283A priority patent/MX9302283A/en
Priority to EP93911769A priority patent/EP0637304A1/en
Priority to PCT/EP1993/000963 priority patent/WO1993022303A1/en
Priority to AU42612/93A priority patent/AU4261293A/en
Priority to ZA932790A priority patent/ZA932790B/en
Priority to CN93105910A priority patent/CN1083475A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
GB929208740A 1992-04-23 1992-04-23 Chemical compounds Pending GB9208740D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB929208740A GB9208740D0 (en) 1992-04-23 1992-04-23 Chemical compounds
IL105375A IL105375A0 (en) 1992-04-23 1993-04-14 Acetic acid derivatives,their preparation and pharmaceutical compositions containing them
JP5518882A JPH07505897A (en) 1992-04-23 1993-04-20 1-Piperazine acetic acid derivatives as fibrinogen receptor antagonists
MX9302283A MX9302283A (en) 1992-04-23 1993-04-20 DERIVATIVES OF ACETIC ACID, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM.
EP93911769A EP0637304A1 (en) 1992-04-23 1993-04-20 1-piperazineacetic derivatives as fibrinogen receptor antagonists
PCT/EP1993/000963 WO1993022303A1 (en) 1992-04-23 1993-04-20 1-piperazineacetic derivatives as fibrinogen receptor antagonists
AU42612/93A AU4261293A (en) 1992-04-23 1993-04-20 1-piperazineacetic derivatives as fibrinogen receptor antagonists
ZA932790A ZA932790B (en) 1992-04-23 1993-04-21 Acetic acid derivatives
CN93105910A CN1083475A (en) 1992-04-23 1993-04-22 Acetogenin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208740A GB9208740D0 (en) 1992-04-23 1992-04-23 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9208740D0 true GB9208740D0 (en) 1992-06-10

Family

ID=10714405

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929208740A Pending GB9208740D0 (en) 1992-04-23 1992-04-23 Chemical compounds

Country Status (9)

Country Link
EP (1) EP0637304A1 (en)
JP (1) JPH07505897A (en)
CN (1) CN1083475A (en)
AU (1) AU4261293A (en)
GB (1) GB9208740D0 (en)
IL (1) IL105375A0 (en)
MX (1) MX9302283A (en)
WO (1) WO1993022303A1 (en)
ZA (1) ZA932790B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4234295A1 (en) * 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carboxylic acid derivatives, medicaments containing these compounds and process for their preparation
PT825184E (en) * 1993-03-29 2001-11-30 Astrazeneca Ab HETEROCYCLIC DERIVATIVES AS PLATELET INHIBITORS
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
ZW4194A1 (en) * 1993-03-29 1994-12-21 Zeneca Ltd Heterocyclic compounds
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
GB9326373D0 (en) * 1993-12-23 1994-02-23 Zeneca Ltd Chemical compounds
GB9326232D0 (en) * 1993-12-23 1994-02-23 Zeneca Ltd Chemical compounds
USRE39263E1 (en) * 1994-05-04 2006-09-05 Bayer Aktiengesellschaft Substituted aromatic thiocarboxylic acid amides and their use as herbicides
CN1113875C (en) * 1994-05-04 2003-07-09 拜尔公司 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
WO1997049698A1 (en) * 1996-06-21 1997-12-31 Glaxo Group Limited Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
AR008245A1 (en) * 1996-06-21 1999-12-29 Glaxo Group Ltd DERIVATIVES OF ACETIC ACID, USE OF THE SAME IN THE MANUFACTURE OF A THERAPEUTIC AGENT AND PROCESS TO PREPARE SUCH DERIVATIVES
DE19743435A1 (en) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidine derivatives
AU2003220110B2 (en) * 2002-03-12 2009-04-09 Wyeth Process for making chiral 1,4-disubstituted piperazines
US7361773B2 (en) 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
AU2003280558A1 (en) * 2002-10-11 2004-05-04 Kowa Co., Ltd. Method for treatment of cancer
WO2007078335A2 (en) * 2005-12-21 2007-07-12 Decode Genetics, Ehf. Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
KR20240035526A (en) 2021-07-07 2024-03-15 바이오젠 엠에이 인코포레이티드 Compounds that target degradation of the IRAK4 protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility

Also Published As

Publication number Publication date
ZA932790B (en) 1994-03-25
WO1993022303A1 (en) 1993-11-11
EP0637304A1 (en) 1995-02-08
MX9302283A (en) 1994-02-28
CN1083475A (en) 1994-03-09
IL105375A0 (en) 1993-08-18
JPH07505897A (en) 1995-06-29
AU4261293A (en) 1993-11-29

Similar Documents

Publication Publication Date Title
GB9201179D0 (en) Chemical compounds
GB9201180D0 (en) Chemical compounds
GB9201038D0 (en) Chemical compounds
GB9202915D0 (en) Chemical compounds
GB9208740D0 (en) Chemical compounds
AP9300585A0 (en) Chemical compounds
GB9209076D0 (en) Chemical compounds
GB9207964D0 (en) Chemical compounds
GB9206989D0 (en) Chemical compounds
GB9205136D0 (en) Chemical compounds
GB9205140D0 (en) Chemical compounds
GB9202840D0 (en) Chemical compounds
GB9201171D0 (en) Chemical compounds
GB9201176D0 (en) Chemical compounds
GB9201182D0 (en) Chemical compounds
GB9201183D0 (en) Chemical compounds
GB9201184D0 (en) Chemical compounds
GB9201196D0 (en) Chemical compounds
GB9201358D0 (en) Chemical compounds
GB9201802D0 (en) Chemical compounds
GB9201821D0 (en) Chemical compounds
GB9202200D0 (en) Chemical compounds
GB9201173D0 (en) Chemical compounds
GB9208495D0 (en) Chemical compounds
GB9201172D0 (en) Chemical compounds